EPO, erythropoietin, 2056

N. diseases: 646; N. variants: 11
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.340 Biomarker disease BEFREE Effect of Empagliflozin on Erythropoietin Levels, Iron Stores and Red Blood Cell Morphology in Patients with Type 2 Diabetes and Coronary Artery Disease. 31707794 2020
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.340 Biomarker disease BEFREE Finally, we will examine the evidence for increased cardiovascular mortality and venous thromboembolic events with the use of erythropoietin-stimulating agents in patients with CAD. 29280914 2018
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.340 AlteredExpression disease BEFREE The correlation between RDW and EPO levels was statistically significant among CAD patients (r=0.411, P<0.001). 28885393 2018
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.340 AlteredExpression disease BEFREE Impact of serum erythropoietin level on collateral vessel development in patients with coronary artery disease. 28315563 2017
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.340 Therapeutic disease CTD_human Turning up the pressure on vascular disease. 25245553 2014